Group items matching

in title, tags, annotations or url

The Tell Every Amazing Lady About Ovarian Cancer Louisa M. McGregor Ovarian Cancer Foundation, also known as T.E.A.L.®, is accepting applications for its 2018 Medical Research Program. The program, which aids in the advancement of ovarian cancer treatment research and the need for a screening test, offers funding in support of ovarian cancer research studies that are deemed to be most aligned with T.E.A.L.®'s mission by the organization's board of directors and a scientific advisory board. This year, the program has special interest in research related to the p53 gene, although it will accept proposals for other research related to ovarian cancer. In 2018, T.E.A.L.® will award one-year grants of up to $60,000. Project costs must be thoroughly outlined in the budget portion of the application, and grants cannot be applied to indirect costs or PI salary. All applicants must be affiliated with a non-for-profit institution in the United States and must complete all sections of the online application found here: https://goo.gl/forms/Bvk0RrwpnnQbYIjC3. (Applications from for profit organizations or federal or state government agencies will not be considered.)

The Shared Instrumentation for Animal Research (SIFAR) Grant Program encourages applications from groups of NIH-funded investigators to purchase or upgrade scientific instruments necessary to carry out animal experiments in all areas of biomedical research supported by the NIH. Applicants may request clusters of commercially available instruments configured as specialized integrated systems or as series of instruments to support a thematic well-defined area of research using animals or related materials. Priority will be given to uniquely configured systems to support innovative and potentially transformative investigations. This FOA supports requests for state-of-the art commercially available technologies needed for NIH-funded research using any vertebrate and invertebrate animal species. This funding opportunity announcement (FOA) does not support requests for single instruments. At least one item of the requested instrumentation must cost at least $50,000, after all applicable discounts. No instrument in a cluster can cost less than $20,000, after all applicable discounts. There is no maximum price requirement; however, the maximum award is $750,000.

The intent of the FY17 ERP IDA is to solicit research to understand the magnitude and underlying mechanisms of PTE. The FY17 ERP IDA offers two levels of funding. Funding Level I is intended to support high-risk or high-gain research from Principal Investigators (PIs) at or above the level of a postdoctoral fellow (or equivalent), but below the level of Assistant Professor (or equivalent). Note that PIs submitting Funding Level I applications will be required to verify their eligibility for this award. Funding Level II is intended to support a more mature, hypothesis-driven research project. To be considered for an FY17 ERP IDA Funding Level II, the PI must be an independent investigator at or above the level of Assistant Professor (or equivalent). While not required, applications to either Funding Level I or II should provide relevant preliminary data. Preliminary data for either Funding Level may come from the PI's published work, pilot data, or from peer-reviewed literature. The requested budget level should be appropriate for the scope of research proposed.For Funding Level I:The anticipated direct costs budgeted for the entire period of performance for an FY17 ERP IDA award will not exceed $300,000. The maximum period of performance is 2 years. For Funding Level II:The anticipated direct costs budgeted for the entire period of performance for an FY17 ERP IDA award will not exceed $500,000. The maximum period of performance is 3 years. FY17 ERP IDA Focus Areas: The research impact for the FY17 ERP IDA is expected to benefit the military, Veteran, and civilian communities.

The purpose of this Funding Opportunity Announcement (FOA) is to stimulate research evaluating the effect of care planning on self-management of late effects of cancer therapy; adherence to medications, cancer screening, and health behavior guidelines; utilization of follow-up care; survivors' health and psychosocial outcomes. How organizational-level factors influence the implementation of care planning and its associated costs is also of interest. Specifically, the FOA aims to stimulate research that will: 1) develop and test metrics for evaluating the impact of survivorship care planning; 2) evaluate the impact of survivorship care planning on cancer survivors' morbidity, self-management and adherence to care recommendations, utilization of follow-up care; 3) evaluate effects of planning on systems outcomes, such as associated costs and impact on providers and organizations implementing the care planning; and 4) identify models and processes of care that promote effective survivorship care planning. The ultimate goal of this FOA is to generate a body of science that will inform the development and delivery of interventions that improve follow-up care for cancer survivors.

The Bureau of International Labor Affairs (ILAB), U.S. Department of Labor announces the availability of approximately $6,000,000 total costs for up to three cooperative agreements of up to $2,000,000 total costs each to fund technical assistance projects to improve the capacity of civil society to better understand and address child labor and/or forced labor abuses and promote acceptable conditions of work in a sector and/or supply chain. The project should achieve the following outcomes: (1) Improved capacity of civil society to identify and document accurate, independent, and objective information on the nature and scope of child labor and/or forced labor, and violations of acceptable conditions of work in a sector and/or supply chain; (2) Improved capacity of civil society to raise awareness for the protection of workers from child labor and/or forced labor abuses, and violations of acceptable conditions of work; and (3) Improved capacity of civil society to implement initiatives to address child labor and/or forced labor and violations of acceptable conditions of work, including facilitated access to grievance mechanisms and/or remedy for victims of labor exploitation. The duration of the project will be a maximum of 4 years (48 months) from the effective date of the award.

The NEI Center Core Grant combines three or more Resource and/or Service Cores for a group of R01 investigators to enhance their research, consolidate resources, avoid duplication of efforts, and/or contribute to cost effectiveness by providing a service with lower costs or higher quality than could be attempted for independent projects by several individual Program Directors/Principal Investigators (PD(s)/PI(s)).

The NEI Center Core Grant combines three or more Resource and/or Service Cores for a group of R01 investigators to enhance their research, consolidate resources, avoid duplication of efforts, and/or contribute to cost effectiveness by providing a service with lower costs or higher quality than could be attempted for independent projects by several individual Program Directors/Principal Investigators (PD(s)/PI(s)). Shared resources and facilities that are accessible to a group of independently funded investigators lead to greater productivity for the separate projects and can provide instrumentation and facilities that are too costly to be maintained by an individual investigator. The design and purpose of each Center Core may vary in how it serves its users. This program is designed to enhance an institution's environment and capability to conduct vision research and to facilitate collaborative studies of the visual system and its disorders.

The purpose of the 2020 HD4A CFP is primarily to award data access at no cost from one of eight anticipated data providers to successful applicants. Most selected projects will not receive a financial award for personnel or other project-related costs. However, limited funding up to $100,000 per project is available for a small number of projects from principal investigators who have not previously received external research funding.

The goal of theBiomedical Engineering(BME)program is to provide research opportunities to develop novel ideas into discovery-level and transformative projects that integrate engineering and life sciences in solving biomedical problems that serve humanity in the long-term. BME projects must be at the interface of engineering and life sciences, and advance both engineering and life sciences. The projects should focus on high impact transformative methods and technologies. Projects should include methods, models and enabling tools of understanding and controlling living systems; fundamental improvements in deriving information from cells, tissues, organs, and organ systems; new approaches to the design of structures and materials for eventual medical use in the long-term; and novel methods for reducing health care costs through new technologies. The long-term impact of the projects can be related to fundamental understanding of cell and tissue function, effective disease diagnosis and/or treatment, improved health care delivery, or product development.

The goal of theBiomedical Engineering(BME)program is to provide research opportunities to develop novel ideas into discovery-level and transformative projects that integrate engineering and life sciences in solving biomedical problems that serve humanity in the long-term. BME projects must be at the interface of engineering and life sciences, and advance both engineering and life sciences. The projects should focus on high impact transformative methods and technologies. Projects should include methods, models and enabling tools of understanding and controlling living systems; fundamental improvements in deriving information from cells, tissues, organs, and organ systems; new approaches to the design of structures and materials for eventual medical use in the long-term; and novel methods for reducing health care costs through new technologies. The long-term impact of the projects can be related to fundamental understanding of cell and tissue function, effective disease diagnosis and/or treatment, improved health care delivery, or product development.

The Healthy, Hunger-Free Kids Act of 2010 (HHFKA) amended Section 18 of the Richard B. Russell National School Lunch Act (NSLA) to establish a Farm to School Program in order to assist eligible entities, through grants and technical assistance, in implementing farm to school programs that improve access to local foods in eligible schools. To fulfill the farm to school mandate in the HHFKA, $5 million is provided to the United States Department of Agriculture (USDA) on an annual basis to support grants, technical assistance, and the Federal administrative costs related to USDA's Farm to School Program. The USDA Farm to School Program is housed within the Food and Nutrition Services' (FNS) Office of Community Food Systems (OCFS). This request for applications (RFA) provides additional details regarding the grants component of the USDA Farm to School Program. The Secretary of Agriculture was also directed through the HHFKA to ensure geographical diversity and equitable treatment of urban, rural, and tribal communities, as well as give the highest priority to funding projects that, as determined by the Secretary - (a) Make local food products available on the menu of the eligible school; (b) Serve a high proportion of children who are eligible for free or reduced price lunches; (c) Incorporate experiential nutrition education activities in curriculum planning that encourage the participation of school children in farm and garden-based activities; (d) Demonstrate collaboration between eligible schools, nongovernmental and community-based organizations, agricultural producer groups, and other community partners; (e) Include adequate and participatory evaluation plans; (f) Demonstrate the potential for long-term program sustainability; and, (g) Meet any other criteria that the Secretary determines appropriate.

The Healthy, Hunger-Free Kids Act of 2010 (HHFKA) amended Section 18 of the Richard B. Russell National School Lunch Act (NSLA) to establish a Farm to School Program in order to assist eligible entities, through grants and technical assistance, in implementing farm to school programs that improve access to local foods in eligible schools. To fulfill the farm to school mandate in the HHFKA, $5 million is provided to the United States Department of Agriculture (USDA) on an annual basis to support grants, technical assistance, and the Federal administrative costs related to USDA's Farm to School Program. The USDA Farm to School Program is housed within the Food and Nutrition Services' (FNS) Office of Community Food Systems (OCFS). This request for applications (RFA) provides additional details regarding the grants component of the USDA Farm to School Program. The Secretary of Agriculture was also directed through the HHFKA to ensure geographical diversity and equitable treatment of urban, rural, and tribal communities, as well as give the highest priority to funding projects that, as determined by the Secretary - (a) Make local food products available on the menu of the eligible school; (b) Serve a high proportion of children who are eligible for free or reduced price lunches; (c) Incorporate experiential nutrition education activities in curriculum planning that encourage the participation of school children in farm and garden-based activities; (d) Demonstrate collaboration between eligible schools, nongovernmental and community-based organizations, agricultural producer groups, and other community partners; (e) Include adequate and participatory evaluation plans; (f) Demonstrate the potential for long-term program sustainability; and, (g) Meet any other criteria that the Secretary determines appropriate.

The Accountable Health Communities (AHC) model addresses a gap in the current delivery system by funding interventions that connect community-dwelling beneficiaries with community services. The AHC model will test three community-focused interventions of varying intensity and their ability to impact total health care costs and inpatient and outpatient health care utilization. This model will engage community-dwelling Medicare and Medicaid beneficiaries of all ages (children and adults). CMS will award, through a competitive process, renewable one-year cooperative agreements to successful applicants (award recipients). This funding opportunity is a second announcement, specifically for Track 1-Awareness. Eligible Applicants interested in a Track 1- Awareness cooperative agreement, including eligible applicants who previously submitted a Track 1 application in response to funding opportunity number CMS-1P1-17-001, must submit an application through grants.gov that is responsive to this funding opportunity announcement. Track 1 will run for a five-year period. Parameters for the Track 1 AHC model are described in this Funding Opportunity Announcement (FOA).

The Accountable Health Communities (AHC) model addresses a gap in the current delivery system by funding interventions that connect community-dwelling beneficiaries with community services. The AHC model will test three community-focused interventions of varying intensity and their ability to impact total health care costs and inpatient and outpatient health care utilization. This model will engage community-dwelling Medicare and Medicaid beneficiaries of all ages (children and adults). CMS will award, through a competitive process, renewable one-year cooperative agreements to successful applicants (award recipients). This funding opportunity is a second announcement, specifically for Track 1-Awareness. Eligible Applicants interested in a Track 1- Awareness cooperative agreement, including eligible applicants who previously submitted a Track 1 application in response to funding opportunity number CMS-1P1-17-001, must submit an application through grants.gov that is responsive to this funding opportunity announcement. Track 1 will run for a five-year period. Parameters for the Track 1 AHC model are described in this Funding Opportunity Announcement (FOA).

The foundation raises funds to support advancement of the AABC birth center model as the standard to improve maternity and women's health care. Based on a wellness model of pregnancy and birth, the birth center is a homelike facility operating within a healthcare system. Birth centers are guided by the principles of prevention of complication, sensitivity to the needs of the individual family, safety for both mother and baby, appropriate use of medical intervention, and cost-effective care. Birth centers provide family-centered care for healthy women before, during, and after normal pregnancy, labor, and birth. To help advance this mission, the foundation will award grants of up to $5,000 in support of research on issues related to the birth center model of care. The program is open to individuals or organizations, and nonprofit status or fiscal sponsorship is not required. However, applicants must be able to demonstrate capacity and a plan to complete the research in accordance with the project's timeline. 

The SES program supports research on strategic decision making, design, planning, and operation of commercial, nonprofit, and institutional service enterprises with the goal of improving their overall effectiveness and cost reduction.  The program has a particular focus on healthcare and other similar public service institutions, and emphasizes research topics leading to more effective systems modeling and analysis as a means to improved planning, resource allocation, and policy development.

Through this solicitation, we seek innovative proposals that apply the principles and frameworks of behavioral economics to persistent and perplexing health and health care problems. We hope to discover new interventions and insight that have potential to dramatically improve the way health care is delivered and health is promoted and preserved. We are particularly interested in supporting experiments that test innovative solutions to the challenge of reducing the use of low-value services in health care. This problem is particularly important given the rising costs and unaffordability of health care in the United States, but has been difficult to impact in part due to perverse incentives in a fee-for-service environment.

This program (formerly, New Investigator Research Grants) is offered by The Obesity Society (TOS), as a member service, to foster and stimulate new research ideas in any area of investigation related to obesity. The program targets junior-level investigators and post-doctoral trainees by funding proposals that demonstrate a high likelihood of resulting in new and innovative approaches in obesity research. Early-career investigators are defined as individuals who have received a PhD within the past five years or MD within the past eight years and who currently hold full-time, entry-level positions (e.g., post-doctoral fellow, instructor, assistant professor) at an established academic/research institution. Applicants may request up to $25,000. No indirect cost will be paid from this grant. Applications (Letters of Intent) are due April 15, 2013, with funding available September 3, 2013. The award may be expended over a period of up to one year.

The purpose of this funding opportunity announcement (FOA) is to emphasize the importance of coordination and collaboration across agencies, partner, and organizations to: * Develop standards and best practices * And to expand the use of electronic data reporting. Specifically, the purpose of this program is to: * Support the development, promotion, maintenance, and communication of data standards for population-based central cancer registration * Improve central cancer registry operations through the development and dissemination of documented best practices. * Increase reporting via electronic mechanisms and meaningful use implementation. The expected outcomes of this FOA are: * Standardized data reporting guidelines and best practices * Improved registry operations * Enhanced national cancer surveillance data * Improved data timeliness, quality, and completeness Approximately $2,250,000 is available to fund one (1) program approximately $450,000 per year for a project period of up to five (5) years. Cost sharing or matching funds are not required for this program. Although there is no statutory match requirement for this FOA, leveraging other resources and related ongoing efforts to promote program continuity is strongly encouraged.

Funding is available for research related to cardiovascular disease and stroke prevention or treatment, or to related clinical and public health problems, including multidisciplinary efforts.  Proposals are encouraged on provider behavior, patient behavior, behavioral outcomes, risk factor outcomes, disease outcomes, cost benefit analyses, efforts to evaluate outcomes of patient care delivery and patient/provider and/or system compliance and adherence to recommendations, as well as pilot clinical research studies that may provide preliminary data for larger-scale investigation. Studies using existing databases are also encouraged.  Ancillary studies or a clearly defined sub-study of an ongoing clinical research study are also encouraged. There must, however, be clear justification that the proposal is a sub-study and not a piece of an already funded project.

The purpose of this funding opportunity announcement (FOA) is to support innovative, multidisciplinary, interactive, and synergistic program projects that integrate basic, translational, and clinical approaches to understanding the developmental biology and genetic basis of significant congenital human malformations. To contain costs, each program project will consist of only three component research projects, as well as associated cores. At least one project must use basic research in an animal model system and at least one project must be clinical or translational in nature. The component research projects must share a common central theme, focus, or objective on a specific major developmental defect or malformation that is genotypically, mechanistically, biologically, or phenotypically analogous or homologous in both animal models and humans. Any non-mammalian or mammalian animal model may be used, as long as it contributes to the common overall theme or objective of the program project.  The component research projects should share a common developmental gene, process, mechanism, pathway, or phenotype.

This Funding Opportunity Announcement (FOA) encourages applications that propose to conduct secondary analyses of alcohol as it relates to chronic disease etiology and epidemiology. The goal of this program is to facilitate innovative yet cost-effective research utilizing previously collected data.

This Funding Opportunity Announcement (FOA) encourages R03 applications that propose to conduct secondary analyses of alcohol as it relates to chronic disease etiology and epidemiology. The goal of this program is to facilitate innovative yet cost-effective research utilizing previously collected data.